Kurtulmus, N. Et Al. 2012. BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. ENDOCRINE , vol.42, no.2 , 404-410.

Kurtulmus, N., Duren, M., İNCE, Ü., YAKICIER, M. C., Peker, O., AYDIN, Ö., ... Altiok, E.(2012). BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. ENDOCRINE , vol.42, no.2, 404-410.

Kurtulmus, Neslihan Et Al. "BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness," ENDOCRINE , vol.42, no.2, 404-410, 2012

Kurtulmus, Neslihan Et Al. "BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness." ENDOCRINE , vol.42, no.2, pp.404-410, 2012

Kurtulmus, N. Et Al. (2012) . "BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness." ENDOCRINE , vol.42, no.2, pp.404-410.

@article{article, author={Neslihan Kurtulmus Et Al. }, title={BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness}, journal={ENDOCRINE}, year=2012, pages={404-410} }